Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Corticosteroid Use and Status in US Males with Duchenne Muscular Dystrophy under the Age of 35, and US Males with Becker Muscular Dystrophy Enrolled in The Duchenne Registry

From: Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry

  Duchenne Becker
Population All Ambulatoryb Nonambulatoryb All
Males with Duchenne Muscular Dystrophy n, (%) N = 1538 N = 845 N = 569 N = 154
Currently using corticosteroids 969 (63.0) 604 (71.5) 277 (48.7) 30 (19.5)
Deflazacort a 524 (54.1) a 344 (57.0) a 132 (47.7) a 21 (70.0) a
Prednisone/prednisolone a 445 (45.9) a 260 (43.0) a 145 (52.3) a 9 (30.0) a
Never used corticosteroids 381 (24.8) 223 (26.3) 131 (23.0) 115 (74.6)
Used to take corticosteroids 188 (12.2) 18 (2.1) 161 (28.3) 9 (5.8)
  1. aPercentages were calculated from number of males currently using corticosteroids as the denominator
  2. bNot all respondents provided ambulatory status